WELL Health Technologies Corp T.WELL

Alternate Symbol(s): WHTCF | T.WELL.DB

Healthcare

WELL Health Technologies Corp. is a practitioner-focused digital healthcare company. The Company develops technologies, services, and support available, which ensures healthcare providers are empowered to positively impact patient outcomes. Its business units include Canadian Patient Services, WELL Health USA Patient Services and SaaS and Technology Services. WELL Health USA Patient and Provider Services includes Primary Circle Medical, Primary WISP, Specialized CRH Medical, and Specialized Provider Staffing. Its healthcare and digital platform includes front and back-office management software applications that help physicians run and secure their practices. Its focused markets include the gastrointestinal market, women's health, primary care and mental health. Its solutions enable 34,000 healthcare providers between the United States and Canada and power owned and operated healthcare’s in Canada with 165 clinics supporting primary care, specialized care and diagnostic services.

TSX:WELL - Post by User

WELL Health Technologies Corp > 5i Comments on price drop

<< Previous

Bullboard Posts

Next >>

Comment by Possibleidiot01on Jan 22, 2024 7:16pm

266 Views

Post# 35839930

RE:5i Comments on price drop

Posted earlier today by retiredcf

Post by retiredcfon Jan 22, 2024 3:51pm

122 Views

Post# 35839587

Rational Thinking

Looks like we are thinking alike.

We don't want to defend analysts much, but we think some of the blame needs to be given to investors who react to downgrades. Nothing has changed at the company. Also, CIBC's target price is still 26% above the current price. CIBC had an $11.50 target in 2021. Analysts tend to follow prices: if a stock goes down, more downgrades occur. We really pay little attention to target prices and would focus on fundamentals. WELL has 16 analysts, and on average they expect EPS to grow by 25% this year. (5iResearch)

danche wrote:
5I RESEARCH ANSWER:

We don't want to defend analysts much, but we think some of the blame needs to be given to investors who react to downgrades. Nothing has changed at the company. Also, CIBC's target price is still 26% above the current price. CIBC had an $11.50 target in 2021. Analysts tend to follow prices: if a stock goes down, more downgrades occur. We really pay little attention to target prices and would focus on fundamentals. WELL has 16 analysts, and on average they expect EPS to grow by 25% this year.